Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -337,00 | 0,00 | Sale to Issuer | - | 33,33k | -1,00% |
| 2026-06-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -81,00 | 0,00 | Sale to Issuer | - | 5,61k | -1,42% |
| 2026-06-01 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -198,00 | 0,00 | Sale to Issuer | - | 5,09k | -3,75% |
| 2026-06-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -208,00 | 0,00 | Sale to Issuer | - | 10,50k | -1,94% |
| 2026-06-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -768,00 | 0,00 | Sale to Issuer | - | 12,73k | -5,69% |
| 2026-06-01 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -109,00 | 0,00 | Sale to Issuer | - | 9,53k | -1,13% |
| 2026-06-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -673,00 | 0,00 | Sale to Issuer | - | 12,21k | -5,22% |
| 2026-06-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,25k | 0,00 | Sale to Issuer | - | 49,84k | -2,45% |
| 2026-06-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -99,00 | 0,00 | Sale to Issuer | - | 8,21k | -1,19% |
| 2026-03-05 | Ms. Cynthia L. FeldmannIndependent Director | -3,10k | 262,99k | Derivative Exercise and Sale | 152,32 - 237,21 | 9,37k | - |
| 2025-11-21 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -5,01k | 669,96k | Derivative Exercise and Sale | 114,22 - 262,00 | 10,71k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,54k | 266,07k | Derivative Exercise and Sale | 182,22 - 258,03 | 5,70k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -1,50k | 386,64k | Vente | 257,76 | 5,70k | -20,85% |
| 2025-11-11 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -15,00k | 2,93M | Derivative Exercise and Sale | 69,72 - 265,14 | 33,67k | - |
| 2025-10-06 | Mr. Daniel A. CarestioPresident, CEO & Director | -159,00 | 38,45k | Vente | 241,82 | 51,10k | -0,31% |
| 2025-10-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -26,00 | 0,00 | Sale to Issuer | - | 7,20k | -0,36% |
| 2025-10-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -91,00 | 0,00 | Sale to Issuer | - | 33,67k | -0,27% |
| 2025-10-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -303,00 | 0,00 | Sale to Issuer | - | 13,49k | -2,20% |
| 2025-10-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -207,00 | 0,00 | Sale to Issuer | - | 12,88k | -1,58% |
| 2025-10-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -52,00 | 0,00 | Sale to Issuer | - | 10,71k | -0,48% |
| 2025-10-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -39,00 | 0,00 | Sale to Issuer | - | 8,30k | -0,47% |
| 2025-10-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -130,00 | 0,00 | Sale to Issuer | - | 51,26k | -0,25% |
| 2025-08-20 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,20k | 327,42k | Derivative Exercise and Sale | 147,05 - 249,24 | 7,22k | - |
| 2025-08-13 | Mr. Richard Carroll BreedenIndependent Director | 4,11k | 263,25k | Derivative Exercise and Retained Stock | 64,05 | 36,66k | 12,63% |
| 2025-08-11 | Dr. Mohsen M. SohiIndependent Chairman of the Board | -4,11k | 731,21k | Derivative Exercise and Sale | 64,05 - 241,96 | 22,36k | - |
| 2025-08-11 | Ms. Cynthia L. FeldmannIndependent Director | -3,50k | 844,25k | Derivative Exercise and Sale | 241,56 | 9,37k | - |
| 2025-08-11 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -7,90k | 1,01M | Derivative Exercise and Sale | 114,22 - 241,73 | 5,99k | - |
| 2025-06-13 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -1,98k | 477,58k | Vente | 240,63 - 241,61 | 33,76k | -5,53% |
| 2025-06-04 | Mr. Michael J. TokichInitié | -341,00 | 82,56k | Sale to Issuer | 242,10 | 47,48k | -0,71% |
| 2025-06-04 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -194,00 | 46,97k | Sale to Issuer | 242,10 | 10,76k | -1,77% |
| 2025-06-04 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -425,00 | 102,89k | Sale to Issuer | 242,10 | 35,74k | -1,18% |
| 2025-06-05 | Mr. Daniel A. CarestioPresident, CEO & Director | -17,63k | 4,28M | Vente | 241,85 - 243,49 | 51,39k | -25,54% |
| 2025-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,92k | 465,07k | Sale to Issuer | 242,10 | 51,39k | -3,60% |
| 2025-06-04 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -154,00 | 37,28k | Sale to Issuer | 242,10 | 6,78k | -2,22% |
| 2025-06-04 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -92,00 | 22,27k | Sale to Issuer | 242,10 | 5,99k | -1,51% |
| 2025-06-04 | Mr. Renato G. TamaroVP & Corporate Treasurer | -66,00 | 15,98k | Sale to Issuer | 242,10 | 7,22k | -0,91% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
